Foster®: Clinical Trials

2 trials of Foster®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Foster®: new trials by email Literature Review of Foster® trials Research Report on Foster®

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation), Foster® 200/6 pMDI (BDP/FF-200/6 µg) - Asthma
Phase 4RecruitingChiesi Farmaceutici S.p.A.6442026-06-282026-07-31
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
CHF5993, CHF1535, Matched placebo - Chronic Obstructive Pulmonary Disease
Phase 4CompletedChiesi Farmaceutici S.p.A.1062021-10-282023-03-24

Conditions studied

Asthma (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Chiesi Farmaceutici S.p.A. (2)

Countries

Bulgaria (1)  ·  Germany (1)

Top investigators

Henrik Watz, MD (1)

Results publications

PMID 39420338

NIH funding

2025 (1)